
An artist’s concept of the nanotrap in action. The nanotrap is shown with a yellow core, green phospholipid shell, and red functionalized particles to bind the virus (shown in gray, decorated with their infamous spike protein in green).
Image courtesy Chen and Rosenberg et al.
Made of FDA-approved polymers and phospholipids, the nanoparticles are about 500 nanometers in diameter—much smaller than a cell. That means the nanotraps can reach more areas inside the body and more effectively trap the virus.
Then, to check to make sure the tiny particles looked the way they expected, they partnered with the lab of Assoc. Prof. Bozhi Tian to use electron microscopes to get a good look. “From our imaging, we saw a solid core and a lipid bilayer shell. That’s the essential part because it mimics the cell,” said Tian, who is appointed in the Department of Chemistry.
The researchers tested the safety of the system in a mouse model and found no toxicity. They then tested the nanotraps against a pseudovirus—a less potent model of a virus that doesn’t replicate—in human lung cells in tissue culture plates and found that they completely blocked entry into the cells.
Once the pseudovirus bound itself to the nanoparticle—which in tests took about 10 minutes after injection—the nanoparticles used a molecule that calls the body’s macrophages to engulf and degrade the nanotrap. Macrophages will generally eat nanoparticles within the body, but the nanotrap molecule speeds up the process. The nanoparticles were cleared and degraded within 48 hours.
The researchers also tested the nanoparticles with a pseudovirus in an ex vivo lung perfusion system—a pair of donated lungs that is kept alive with a ventilator—and found that they completely blocked infection in the lungs.
They also collaborated with researchers at Argonne National Laboratory to test the nanotraps with a live virus (rather than a pseudovirus) in an in vitro system. They found that their system inhibited the virus 10 times better than neutralizing antibodies or soluble ACE2 alone.
A potential future treatment for COVID-19 and beyond
Next the researchers hope to further test the system, including more tests with a live virus and on the many virus variants.
“That’s what is so powerful about this nanotrap,” Rosenberg said. “It’s easily modulated. We can switch out different antibodies or proteins or target different immune cells, based on what we need with new variants.”
The nanotraps can be stored in a standard freezer and could ultimately be given via an intranasal spray, which would place them directly in the respiratory system and make them most effective.
The nanotraps can be stored in a standard freezer and could ultimately be given via an intranasal spray.
The researchers say it is also possible to serve as a vaccine by optimizing the formulation.
“This nanomaterial engineering approach provides a versatile platform to clear viruses, and paves the way for designing next-generation vaccines and therapeutics,” said co-author and graduate student Jiuyun Shi.
“This is the starting point,” Huang said. “We want to do something to help the world.”
Original Article: UChicago scientists design ‘nanotraps’ to catch and clear coronavirus from tissue
More from: University of Chicago | Argonne National Laboratory
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Nanotraps capture SARS-CoV-2
- Erythema multiforme major associated with SARS-CoV-2 infection in a patient with skin of colour
A 38-year-old man with Fitzpatrick type V skin presented to the emergency department with a 2-week history of fever, productive cough, rhinorrhea and 5 days of oral pain. He was otherwise healthy and ...
- Study finds that SARS-CoV-2 can shut down mitochondria, the cellular “power plants”
A recent study published by the journal Science Translational Medicine found that SARS-CoV-2 infection inhibits the ability of mitochondria to produce energy in the body’s cells. This is the ...
- SARS CoV 2 News and Research
This review in Cellular and Molecular Immunology delves into the innate immune response to SARS-CoV-2, exploring how the virus evades immunity and the potential role of innate immunity in long ...
- SARS-CoV-2 articles from across Nature Portfolio
SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). The spike protein of BA.2.86 — a subvariant of ...
- QIAseq DIRECT SARS-CoV-2 Kits
Single-box solution containing all materials for reverse transcription and library preparation with 96 Unique Dual Indices (Set A) QIAseq DIRECT SARS-CoV-2 Kits are intended for molecular biology ...
Go deeper with Google Headlines on:
Nanotraps capture SARS-CoV-2
[google_news title=”” keyword=”nanotraps capture SARS-CoV-2″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Nanotraps
- The emergence of spin electronics in data storage
Electrons have a charge and a spin, but until recently these were considered separately. In classical electronics, charges are moved by electric fields to transmit information and are stored in a ...
- Pritzker School of Molecular Engineering at the University of Chicago’s Post
A new way to catch and clear coronavirus from your body: Nanotraps. Developed at PME, these nanoparticles bind to the virus and recruit the body’s own immune system to destroy it.
- Superconducting Vortex Lattices for Ultracold Atoms
@article{PhysRevLett.111.145304, added-at = {2019-02-26T15:22:34.000+0100}, author = {Romero-Isart, O. and Navau, C. and Sanchez, A. and Zoller, P. and Cirac, J. I ...
- Toroidal nanotraps for cold polar molecules
Electronic excitations in metallic nanoparticles in the optical regime that have been of great importance in surface-enhanced spectroscopy and emerging applications of molecular plasmonics, due to ...
Go deeper with Google Headlines on:
Nanotraps
[google_news title=”” keyword=”nanotraps” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]